UBS keeps Hold rating for Sundrug stock at JPY 3,820.00

Published on 10/19/2026 at 04:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UBS maintains a JPY 3,820 target for Sundrug stock on October 6, 2026. First-quarter revenue reached JPY 215.3 billion, up 3.7 percent.

Signals for the next report

UBS maintained a JPY 3,820.00 target on October 6, 2026.
First-quarter revenue reached JPY 215.3 billion, up 3.7 percent year over year.
Sundrug had a JPY 431.5 billion market capitalization as of October 19, 2026.

Sundrug, JP3336600006, Illustration mit AI erstellt.

Sundrug (JP3336600006) has a JPY 3,820.00 analyst target after Markets Insider reported on October 6, 2026 that UBS maintained its Hold rating. The target gives the latest market view a concrete reference point ahead of Sundrug's next scheduled results.

Three dated signals shape the stock

The recent chronology starts with first-quarter fiscal 2027 results on August 16, 2026, when revenue reached JPY 215.3 billion, up 3.7 percent from the comparable period, while net income was JPY 8.02 billion. Simply Wall St carried the period figures and said earnings per share missed expectations by 1.4 percent.

On September 29, 2026, Sundrug's JPY 66.00 dividend per share went ex-dividend, according to the same Simply Wall St company timeline. UBS then maintained its Hold rating and set a JPY 3,820.00 target on October 6, 2026, making the analyst view the latest dated event.

What does the target mean?

The JPY 3,820.00 target sits above the JPY 3,689 last price reported for October 19, 2026 at 10:57 a.m. JST on the Tokyo Stock Exchange. The difference is JPY 131.00, while the latest quarterly revenue growth was 3.7 percent and net income was JPY 8.02 billion. The combination points to a stock story built on sales expansion, but with earnings expectations and expenses still central to the debate.

Two dates set the next test

Simply Wall St lists November 13, 2026 as Sundrug's next reporting date. The JPY 66.00 dividend is scheduled for payment on December 1, 2026, giving shareholders a second dated item after the results appointment.

Market value and retail scale

Sundrug had a JPY 431.5 billion market capitalization as of October 19, 2026, while its 52-week range stood at JPY 3,506.00 to JPY 4,466.00. The company operates drug stores and discount stores in Japan, with pharmaceuticals, cosmetics, daily necessities, food and household goods among its main categories.